uniQure (QURE) Net Margin (2016 - 2026)

uniQure (QURE) posted quarterly Net Margin of 1387.76% for Q2 2026, down 67094.0% year-over-year from N/an in Q2 2025, and up 7.66% quarter-over-quarter from 1502.95% in Q1 2026.

uniQure (QURE) Net Margin (2016 - 2026) Analysis & Trends

uniQure's Net Margin history runs 11 years deep, the most recent figure standing at 1387.76% for Q2 2026.

  • In Q2 2026, Net Margin fell 67094.0% year-over-year to 1387.76%; the TTM figure through Jun 2026 stood at 1053.43% (up 33455.0% YoY), while the FY2025 annual figure was 1236.0%, down 35265.0% from the prior year.
  • Net Margin for Q2 2026 stood at 1387.76%, up from 1502.95% in the prior quarter.
  • The five-year high for Net Margin was 330.94% in Q4 2025, with the low at 7859.36% in Q2 2022.
  • The 5-year median for Net Margin is 1476.61% (2026), against an average of 2131.03%.
  • Peak annual rise in Net Margin reached 654850 bps in 2022, while the deepest fall reached 794547 bps in 2022.
  • uniQure's Net Margin stood at 6.63% in 2022, then tumbled by 16619 bps to 1094.42% in 2023, then declined by 28 bps to 1403.2% in 2024, then surged by 124 bps to 330.94% in 2025, then tumbled by 519 bps to 1387.76% in 2026.
  • Business Quant data shows QURE's Net Margin at 1387.76% in Q2 2026, 1502.95% in Q1 2026, and 330.94% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 uniQure 3.37 Bn 3.37 Bn 5.49 Mn -1,387.76%

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,387.76%
Mar 31, 2026 -1,502.95%
Dec 31, 2025 330.94%
Sep 30, 2025 -2,175.87%
Jun 30, 2025 -716.82%
Mar 31, 2025 -2,784.75%
Dec 31, 2024 -1,403.20%
Sep 30, 2024 -1,940.45%
Jun 30, 2024 -506.01%
Mar 31, 2024 -773.34%
Dec 31, 2023 -1,094.42%
Sep 30, 2023 -6,366.10%
Jun 30, 2023 -2,827.17%
Mar 31, 2023 -1,450.27%
Dec 31, 2022 6.63%
Sep 30, 2022 -3,302.76%
Jun 30, 2022 -7,859.36%
Mar 31, 2022 -2,604.80%
Dec 31, 2021 14.23%
Sep 30, 2021 -1,836.65%